Rathbones Group PLC Novartis Ag Transaction History

Rathbones Group PLC

  • $19 Billion
  • Q3 2024

A detailed history of Rathbones Group PLC transactions in Novartis Ag stock. As of the latest transaction made, Rathbones Group PLC holds 56,203 shares of NVS stock, worth $5.83 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
56,203
Previous 58,060 3.2%
Holding current value
$5.83 Million
Previous $6.18 Million 4.58%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $197,083 - $224,492
-1,857 Reduced 3.2%
56,203 $6.46 Million
Q2 2024

Aug 09, 2024
SELL
$92.57 - $107.37 $149,407 - $173,295
-1,614 Reduced 2.7%
58,060 $6.18 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $197,304 - $224,641
-2,071 Reduced 3.35%
59,674 $5.77 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $282,069 - $310,407
-3,057 Reduced 4.72%
61,745 $6.23 Million
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $397,676 - $441,335
4,198 Added 6.93%
64,802 $6.6 Million
Q2 2023

Aug 04, 2023
SELL
$92.52 - $104.91 $105,287 - $119,387
-1,138 Reduced 1.84%
60,604 $6.12 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $371,579 - $430,916
-4,643 Reduced 6.99%
61,742 $5.68 Million
Q4 2022

Feb 14, 2023
SELL
$75.55 - $92.52 $1.15 Million - $1.41 Million
-15,276 Reduced 18.71%
66,385 $6.02 Million
Q3 2022

Nov 03, 2022
SELL
$74.61 - $87.26 $161,530 - $188,917
-2,165 Reduced 2.58%
81,661 $6.21 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $505,665 - $588,750
-6,280 Reduced 6.97%
83,826 $7.09 Million
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $236,404 - $267,419
-2,951 Reduced 3.17%
90,106 $7.91 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $114,927 - $127,083
-1,442 Reduced 1.53%
93,057 $8.14 Million
Q3 2021

Nov 04, 2021
SELL
$81.78 - $95.14 $17,419 - $20,264
-213 Reduced 0.22%
94,499 $7.73 Million
Q2 2021

Jul 30, 2021
SELL
$85.24 - $94.15 $148,829 - $164,385
-1,746 Reduced 1.81%
94,712 $8.64 Million
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $87,591 - $103,295
-1,049 Reduced 1.08%
96,458 $8.25 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $140,291 - $169,690
-1,797 Reduced 1.81%
97,507 $9.21 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $29,816 - $33,033
-363 Reduced 0.36%
99,304 $8.64 Million
Q2 2020

Aug 07, 2020
SELL
$80.93 - $91.1 $26,059 - $29,334
-322 Reduced 0.32%
99,667 $8.71 Million
Q1 2020

May 04, 2020
SELL
$70.67 - $99.01 $2,826 - $3,960
-40 Reduced 0.04%
99,989 $8.24 Million
Q4 2019

Feb 11, 2020
BUY
$84.35 - $95.37 $96,327 - $108,912
1,142 Added 1.15%
100,029 $9.47 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $8.46 Million - $9.32 Million
98,887 New
98,887 $8.59 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email